KR20170141952A - Method for manufacturing old antler and Auricularia judae fermented solution by lactic acid fermentation and food composition for improving inflammation comprising the fermented solution - Google Patents

Method for manufacturing old antler and Auricularia judae fermented solution by lactic acid fermentation and food composition for improving inflammation comprising the fermented solution Download PDF

Info

Publication number
KR20170141952A
KR20170141952A KR1020160075025A KR20160075025A KR20170141952A KR 20170141952 A KR20170141952 A KR 20170141952A KR 1020160075025 A KR1020160075025 A KR 1020160075025A KR 20160075025 A KR20160075025 A KR 20160075025A KR 20170141952 A KR20170141952 A KR 20170141952A
Authority
KR
South Korea
Prior art keywords
lactic acid
extract
fermentation
fermented
gaba
Prior art date
Application number
KR1020160075025A
Other languages
Korean (ko)
Other versions
KR101826148B1 (en
Inventor
이삼빈
권순영
임종순
박은진
허담
이지원
Original Assignee
계명대학교 산학협력단
(주)옴니허브
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 계명대학교 산학협력단, (주)옴니허브 filed Critical 계명대학교 산학협력단
Priority to KR1020160075025A priority Critical patent/KR101826148B1/en
Publication of KR20170141952A publication Critical patent/KR20170141952A/en
Application granted granted Critical
Publication of KR101826148B1 publication Critical patent/KR101826148B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/02Acid
    • A23V2250/038Gamma-amino butyric acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/204Animal extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/208Fungi extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/169Plantarum
    • A23Y2220/67

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a method for manufacturing Cervus Nippon and Auricularia auricula-judae fermented solution through lactic acid fermentation and to a food composition for alleviating inflammation comprising the fermented solution as an active ingredient, and more specifically, to a method for manufacturing a composition for alleviating inflammation having reinforced dietary fiber, high-concentration GABA and probiotics by performing selective extraction of useful components by stepwise hydrothermal extraction of the Cervus Nippon and using lactic acid bacteria of Kimchi with a mixture of a Cervus Nippon extract and an Auricularia auricula-judae powder. In the present invention, Cervus Nippon and Auricularia auricula-judae fermented solution having reinforced GABA and dietary fiber were manufactured through the method, and a functional food material having antioxidant and anti-inflammatory effects were developed.

Description

젖산 발효를 통한 녹각 및 목이버섯 발효액 제조방법 및 상기 발효액을 유효성분으로 포함하는 염증 개선용 식품조성물{Method for manufacturing old antler and Auricularia judae fermented solution by lactic acid fermentation and food composition for improving inflammation comprising the fermented solution}TECHNICAL FIELD [0001] The present invention relates to a method for preparing a fermented liquid of fermented green algae and throat mushroom by lactic acid fermentation and a composition for improving inflammation comprising the fermented liquid as an active ingredient }

본 발명은 젖산 발효를 통한 녹각 및 목이버섯 발효액 제조방법 및 상기 발효액을 유효성분으로 포함하는 염증 개선용 식품조성물에 관한 것으로, 더욱 상세하게는 녹각의 단계적인 열수 추출에 의해서 유용성분을 선택적으로 추출한 후 녹각 추출물과 목이버섯 분말 혼합물을 김치 젖산균을 이용하여 식이섬유, 고농도 GABA와 프로바이오틱스(probiotics)가 강화된 염증완화 조성물 제조방법에 대한 것이다.The present invention relates to a method for preparing a fermented liquid of Lactobacillus thuringiensis and Lactobacillus acidus through lactic acid fermentation and a food composition for improving inflammation comprising the fermentation broth as an active ingredient. More particularly, The present invention relates to a method for producing an inflammation-reducing composition having enhanced dietary fiber, high-concentration GABA and probiotics by using lactic acid bacteria of the genus Kimchi,

목이버섯 등의 식용버섯은 대표적인 기호식품으로 풍부한 식이섬유, 다양한 영양성분과 고유한 풍미를 지니고 있어 대표적인 건강식품소재이다. 목이버섯은 식이섬유 함량이 매우 높으며, 비타민 D가 풍부하여 여성 건강에 좋은 식용버섯이다. 특히, 목이버섯은 식약처의 건강기능식품 기능성 원료로서 “배변활동 원활”의 기능성이 인정되었다. 최근 인공재배로 생산되는 식용버섯의 효능평가 등을 통한 고부가가치 소재화에 대한 연구개발이 요구된다. 또한, 버섯을 건강 식품소재 및 고부가가치 소재로 활용하기 위한 방안으로, 발효에 의해 유용 물질의 생성으로 기능성물질이 강화된 소재를 개발하여 식품 및 건강식품의 소재로 활용이 필요하다. Edible mushrooms such as thorny mushroom are representative typical foods, and they are rich in dietary fiber, various nutritional ingredients and unique flavors, and are a typical health food material. Thirsty mushroom is very high in dietary fiber content, and is rich in vitamin D. In particular, the function of "smooth bowel activity" was recognized as a functional ingredient of health functional foods in the food industry. Recently, it is required to research and develop high value added materials through evaluation of efficacy of edible mushroom produced by artificial cultivation. In order to utilize mushroom as a health food material and high value added material, it is necessary to develop a material in which a functional material is reinforced by the production of a useful substance by fermentation and utilize it as a material for food and health food.

젖산균은 GRAS(Generally Recognized As Safe: 미국 FDA 에서 지정한 일반적으로 안전한 물질) 균주로 대표적인 프로바이오틱스(probiotics: 장내 건강에 도움을 주는 살아있는 생균) 미생물로 알려져 있다. 젖산균은 전통발효식품에서 당으로부터 젖산을 생산하며, 동서양의 김치, 발효유 등 발효식품의 스타터로 이용되고 있다. 최근 젖산균이 정장작용, 아토피, 관절염 같은 면역질환을 치료하는데 효과가 있다는 연구보고가 되면서 젖산균을 이용한 발효제품에 대한 제품화가 활발하다. 특히, 젖산균이 생산하는 생리활성물질은 항균물질, 펩타이드 및 GABA(gamma-butyric acid) 등을 포함한다. Lactic acid bacteria are generally known as probiotics (live live bacteria that help the intestinal health) as GRAS (Generally Recognized As Safe). Lactic acid bacteria produces lactic acid from sugar in traditional fermented foods and is used as a starter for fermented foods such as kimchi and fermented milk in the east and the west. Recently, lactic acid bacteria have been reported to be effective in treating immune diseases such as suicide, atopy and arthritis, and fermented products using lactic acid bacteria have been commercialized. In particular, physiologically active substances produced by lactic acid bacteria include antimicrobial substances, peptides and gamma-butyric acid (GABA).

L-글루탐산(L-glutamic acid)은 신경세포 활성을 유도하는 물질로 알려져 있으며, 글루타메이드 디카르복실레이즈(glutamate decarboxylase; GAD, EC 4.1.1.15)에 의해 r-아미노뷰티르산(r-aminobutyric acid; GABA)으로 전환된다. GABA는 억제성 신경전달물질로서 뇌 혈류개선, 스트레스 해소, 기억력 증진, 혈압강하작용, 우울증 완화, 비만 등에 효과가 있는 것으로 알려져 다양한 제품개발이 이루어지고 있다. 자연에서 얻을 수 있는 식물체 GABA 함유량은 약리작용을 발휘하기에 미량으로 미생물을 이용한 GABA 함량을 증대시키고 이를 다양한 제품에 이용하고 있다.  L-glutamic acid is known as a substance that induces neuronal activity and is activated by glutamate decarboxylase (GAD, EC 4.1.1.15), r-aminobutyric acid acid (GABA). GABA is an inhibitory neurotransmitter that has been known to be effective in improving cerebral blood flow, relieving stress, improving memory, lowering blood pressure, relieving depression, and obesity. The plant GABA content, which can be obtained from nature, increases the GABA content using microorganisms because it exerts a pharmacological effect and uses it in various products.

한국공개특허 제10-2015-0102327호(2015.09.07 공개)Korean Patent Publication No. 10-2015-0102327 (published on Sep. 20, 2015)

본 발명의 목적은 락토바실러스 플란타륨(Lactobacillus plantarum) EJ2014 (KCCM11545P)을 이용한 젖산 발효를 통해, 항산화 활성 및 감마-아미노뷰티르산(gammaaminobutyric acid; GABA) 등의 기능성 물질이 강화된 녹각추출물 및 목이버섯 복합 젖산발효액을 생산하는 방법을 제공하는데 있다. It is an object of the present invention to provide a method of producing lactic acid bacteria which comprises fermenting lactic acid using Lactobacillus plantarum EJ2014 (KCCM11545P), antioxidative activity and a functional substance such as gammaaminobutyric acid (GABA) Mushroom complex lactic acid fermentation broth.

상기 목적을 달성하기 위하여, 본 발명은 (1) 녹각을 열수 추출하여 녹각 추출액을 제조하는 단계; (2) 상기 제조된 녹각 추출액에 목이버섯, 모노소듐 글루타메이트(monosodium glutamate; MSG), 포도당(glucose) 및 효모 추출물(yeast extract)를 첨가하여 혼합하는 단계; (3) 상기 혼합물을 열처리하는 단계; 및 (4) 상기 열처리된 혼합물에 젖산균(Lactobacillus) 스타터를 접종하고 배양하여 젖산 발효시키는 단계를 포함하는 항산화 활성 및 감마-아미노뷰티르산(gammaaminobutyric acid; GABA) 증진된 녹각추출물 및 목이버섯 복합 젖산발효액 제조방법을 제공한다.In order to accomplish the above object, the present invention provides a method for producing a green algae extract, comprising the steps of: (1) (2) adding and mixing monosodium glutamate (MSG), glucose, and yeast extract to the above-prepared extract of green tea leaves; (3) heat treating the mixture; And (4) incubating the heat-treated mixture with a Lactobacillus starter and incubating and fermenting the lactic acid, and an antioxidant activity and gamma-aminobutyric acid (GABA) -enhanced edible oil extract, And a manufacturing method thereof.

또한, 본 발명은 락토바실러스 플란타륨(Lactobacillus plantarum) EJ2014 (KCCM11545P) 균주로 발효시킨 녹각추출물 및 목이버섯 복합 젖산발효액을 유효성분으로 포함하는 염증 개선용 식품조성물을 제공한다.In addition, the present invention provides a food composition for improving inflammation, comprising as an active ingredient, a green tea extract and a fermented liquid mixture of lactic acid fermented with Lactobacillus plantarum EJ2014 (KCCM11545P).

본 발명은 젖산 발효를 통한 녹각 및 목이버섯 발효액 제조방법 및 상기 발효액을 유효성분으로 포함하는 염증 개선용 식품조성물에 관한 것으로, 더욱 상세하게는 녹각의 단계적인 열수 추출에 의해서 유용성분을 선택적으로 추출한 후 녹각 추출물과 목이버섯 분말 혼합물을 김치 젖산균을 이용하여 식이섬유, 고농도 GABA와 프로바이오틱스(probiotics)가 강화된 염증완화 조성물 제조방법에 대한 것이다. 본 발명에서는 상기와 같은 방법을 통하여 GABA 및 식이섬유가 강화된 녹각 및 목이버섯 발효물을 생산하였으며, 이들의 항산화 및 염증완화 효과를 가지는 기능성 식품 소재를 개발하였다. The present invention relates to a method for preparing a fermented liquid of Lactobacillus thuringiensis and Lactobacillus acidus through lactic acid fermentation and a food composition for improving inflammation comprising the fermentation broth as an active ingredient. More particularly, The present invention relates to a method for producing an inflammation-reducing composition having enhanced dietary fiber, high-concentration GABA and probiotics by using lactic acid bacteria of the genus Kimchi, In the present invention, a functional food material having antioxidative and anti-inflammatory effects was produced by producing the fermented product of GABA and dietary fiber fortified with the above-mentioned method.

도 1은 녹각 추출 및 젖산 발효 공정도를 나타낸다.
도 2는 녹각 추출물의 MSG 첨가 함량에 따른 산도와 pH 변화를 나타낸다.
도 3은 MSG 농도에 따른 젖산균의 발효기간 동안 생균수 변화를 나타낸다.
도 4는 녹각 추출물의 목이버섯 첨가 유무에 따른 젖산 발효물의 GABA 생성을 나타낸다.
도 5는 목이버섯 및 녹각 추출물의 MSG 농도에 따른 젖산 발효물의 GABA 생성을 나타낸다.
도 6은 목이버섯 첨가 전 녹각추출액의 세포 생존율을 나타낸다.
도 7은 목이버섯 첨가 후 녹각추출액의 세포 생존율을 나타낸다.
도 8은 목이버섯 첨가 전 녹각추출액의 NO 생성 비교 결과를 나타낸다.
도 9는 목이버섯 첨가 후 녹각추출액의 NO 생성 비교 결과를 나타낸다.
Fig. 1 shows a process for extracting corn germ oil and lactic acid fermentation.
FIG. 2 shows the acidity and the pH change according to the MSG content of the extract of the green tea extract.
Fig. 3 shows changes in the number of live cells during the fermentation period of lactic acid bacteria according to MSG concentration.
Fig. 4 shows GABA production of fermented lactic acid according to the presence or absence of throat mushroom in the extract of green tea.
Figure 5 shows GABA production of lactic acid fermentations according to the MSG concentration of the mushroom and green onion extracts.
Fig. 6 shows the cell survival rate of the extract of Angelica keiskei koidz.
FIG. 7 shows the cell survival rate of the extract of the green tea extract after addition of the mushroom.
Fig. 8 shows the results of NO production of the extract from the green wing before the addition of the mushroom.
FIG. 9 shows the results of NO production of the extract of the green tea extract after addition of the mushroom.

이에, 본 발명자들은 녹각 추출물에 목이버섯을 고형분 함량 기준으로 2.5%~10% 범위에서 첨가한 후, 멸균시켜서 김치 유래 젖산균을 접종하여 기능성 물질인 GABA 생산을 최적화하였다. GABA 생산 및 기능성 물질의 강화를 위해서 비타민 D와 식이섬유가 풍부한 목이버섯과 소듐 글루타메이트(sodium glutamate)를 5% 수준으로 첨가하여 젖산 발효 배지를 조성하였다. GABA 생산능이 우수한 김치 젖산균을 1% 수준으로 접종하여 30℃에서 정치배양으로 7일 동안 발효를 수행하였으며, 이를 통해서 프로바이오틱스, GABA 및 식이섬유가 강화된 녹각발효물을 생산하였으며, 이들의 항산화 및 염증완화 효능평가를 통해서 기능성 녹각 복합 발효조성물을 제조하고 본 발명을 완성하였다. The present inventors optimized the production of GABA, a functional material, by adding lactic acid bacteria derived from Kimchi to the extracts of green tea leaves, adding throat mushroom in the range of 2.5% to 10% based on the solid content, and sterilizing. For the production of GABA and the enhancement of functional materials, lactic acid fermentation medium was prepared by adding 5% of vitamin D and dietary fiber - rich mushroom and sodium glutamate. GABA lactic acid bacteria were inoculated at 1% level and fermented at 30 ℃ for 7 days. This resulted in fermentation of probiotics, GABA and dietary fibers, and their antioxidant and inflammation The present inventors have completed the present invention by preparing a functional fermented starch complex composition through evaluation of relaxation efficacy.

본 발명은 (1) 녹각을 열수 추출하여 녹각 추출액을 제조하는 단계; (2) 상기 제조된 녹각 추출액에 목이버섯, 모노소듐 글루타메이트(monosodium glutamate; MSG), 포도당(glucose) 및 효모 추출물(yeast extract)를 첨가하여 혼합하는 단계; (3) 상기 혼합물을 열처리하는 단계; 및 (4) 상기 열처리된 혼합물에 젖산균(Lactobacillus) 스타터를 접종하고 배양하여 젖산 발효시키는 단계를 포함하는 항산화 활성 및 감마-아미노뷰티르산(gammaaminobutyric acid; GABA) 증진된 녹각추출물 및 목이버섯 복합 젖산발효액 제조방법을 제공한다. The present invention relates to (1) a method for preparing a green algae extract by hydrothermal extraction of a green algae; (2) adding and mixing monosodium glutamate (MSG), glucose, and yeast extract to the above-prepared extract of green tea leaves; (3) heat treating the mixture; And (4) incubating the heat-treated mixture with a Lactobacillus starter and incubating and fermenting the lactic acid, and an antioxidant activity and gamma-aminobutyric acid (GABA) -enhanced edible oil extract, And a manufacturing method thereof.

바람직하게는, 상기 (2) 단계는 전체 녹각 추출액 100 중량부에 대해, 목이버섯 0.1 내지 10 중량부, MSG 1 내지 5 중량부, 포도당(glucose) 1 내지 5 중량부 및 효모 추출물(yeast extract) 0.1 내지 3 중량부를 첨가하여 혼합될 수 있으나, 이에 제한되는 것은 아니다.Preferably, the step (2) comprises, by weight, 0.1 to 10 parts by weight of mushroom, 1 to 5 parts by weight of MSG, 1 to 5 parts by weight of glucose, and yeast extract, 0.1 to 3 parts by weight may be added and mixed, but the present invention is not limited thereto.

바람직하게는, 상기 (4) 단계의 발효는 25 내지 30℃에서, 1 내지 10일 동안 발효할 수 있으나, 이에 제한되는 것은 아니다.Preferably, the fermentation in the step (4) may be performed at 25 to 30 DEG C for 1 to 10 days, but is not limited thereto.

본 발명의 실시예에서 사용된 락토바실러스 플란타륨(Lactobacillus plantarum) EJ2014 균주는 한국미생물보존센터에 KCCM11545P로 수탁하였다.The Lactobacillus plantarum strain EJ2014 used in the examples of the present invention was deposited with KCCM11545P at the Korean Microorganism Conservation Center.

본 발명에 있어서, "스타터(starter)"란 발효물을 제조하는 경우에 사용하는 미생물 배양액을 말한다. 따라서 스타터 미생물의 종류는 그 제품의 특성을 결정하게 되며 제품의 품질에 중요한 영향을 미친다. 미생물 중에서 스타터로 사용되고 있는 것은 박테리아, 곰팡이, 효모 등을 들 수 있으며, 이것을 단독 혹은 혼합하여 사용할 수 있다.In the present invention, the term "starter" refers to a culture medium of microorganisms used for producing a fermented product. Therefore, the types of starter microorganisms determine the characteristics of the product and have an important influence on the quality of the product. Bacteria, fungi, yeast, etc., which are used as starters in microorganisms, can be used alone or in combination.

또한, 본 발명은 상기의 방법에 의해 제조된 항산화 활성 및 GABA 증진된 녹각추출물 및 목이버섯 복합 젖산발효액을 제공한다.The present invention also provides an antioxidative activity, a GABA enhanced edible oil extract, and a fermented broth of Lactobacillus acidus produced by the above method.

또한, 본 발명은 락토바실러스 플란타륨(Lactobacillus plantarum) EJ2014 (KCCM11545P) 균주로 발효시킨 녹각추출물 및 목이버섯 복합 젖산발효액을 유효성분으로 포함하는 염증 개선용 식품조성물을 제공한다.In addition, the present invention provides a food composition for improving inflammation, comprising as an active ingredient, a green tea extract and a fermented liquid mixture of lactic acid fermented with Lactobacillus plantarum EJ2014 (KCCM11545P).

상세하게는, 상기 녹각추출물 및 목이버섯 복합 젖산발효액은 항산화 활성 및 GABA가 증진될 수 있다.In detail, the antioxidant activity and GABA can be enhanced by the fermented liquid of the extract of the green algae and the combined fermented lycopersicum lactic acid.

본 발명에 있어서, "감마-아미노뷰티르산(gammaaminobutyric acid; GABA)"은 억제성 신경전달물질로서 뇌 혈류개선, 스트레스 해소, 기억력 증진, 혈압강하작용, 우울증 완화, 비만 등에 효과가 있는 것으로 알려져 다양한 제품개발이 이루어지고 있다. 자연에서 얻을 수 있는 식물체 GABA 함유량은 약리작용을 발휘하기에 미량으로 미생물을 이용한 GABA 함량을 증대시키고 이를 다양한 제품에 이용하고 있다.In the present invention, "gamma-aminobutyric acid (GABA)" is an inhibitory neurotransmitter, which is known to be effective in improving cerebral blood flow, relieving stress, improving memory, lowering blood pressure, relieving depression, Product development is being done. The plant GABA content, which can be obtained from nature, increases the GABA content using microorganisms because it exerts a pharmacological effect and uses it in various products.

본 발명의 식품 조성물인 경우, 상기 식품의 종류에는 특별한 제한은 없다. 상기 발효액을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있다. In the case of the food composition of the present invention, there is no particular limitation on the kind of the food. Examples of the food to which the fermentation broth can be added include dairy products including meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen noodles, gums, ice cream, soups, drinks, tea, Alcoholic beverages and vitamin complexes.

이하, 하기 실시예를 통해 본 발명을 보다 상세하게 설명한다. 다만, 이러한 실시예에 의해 본 발명이 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the present invention is not limited by these examples.

<< 실시예Example 1> 녹각 추출물 제조 및 젖산 발효  1> Preparation of Extracts of Green Crab and Lactic Acid Fermentation

1. 녹각 추출물 제조1. Manufacture of green algae extract

증류수 10L에 녹각 500g 넣은 후 고온에서 40시간 동안 추출한 후 여액을 얻는다. 열수 추출된 녹각추출물(100mL)은 목이버섯 2.5g, MSG 2.5%~4.5%, 포도당(glucose) 1.5% 및 YE 0.5%와 혼합된 후 121℃에서 15분간 열처리 하였다. 그리고 각각의 시료에 락토바실러스 플란타륨(L. plantarum) EJ2014 스타터(starter)를 1% 접종하고 30℃ 인큐베이터에서 7일간 배양한 후 발효물을 제조하였다(도 1).After adding 500 g of green tea to 10 L of distilled water, the solution is extracted at high temperature for 40 hours. The extracts of hot water extracts (100 mL) were mixed with 2.5 g of mushroom, 2.5 ~ 4.5% of MSG, 1.5% of glucose and 0.5% of YE and then heat treated at 121 캜 for 15 minutes. And was a Lactobacillus Planta volume (L. plantarum) EJ2014 starter (starter) on each sample inoculated with 1% to prepare a fermented product and incubated at 30 ℃ incubator 7 days (Fig. 1).

2. 결과 및 고찰2. Results and discussion

(1) 고형분 함량, pH, 산도 및 생균수 변화(1) Solid content, pH, acidity and viable cell number change

녹각 추출액 젖산 발효물의 pH는 MSG 첨가 농도 증가에 따라서 발효기간 중에 증가하는 경향을 보였다. MSG 2.5% 첨가의 경우에 발효 1일에 pH 4.3으로 떨어졌고 발효 3일에 약간 증가하면서 pH 4.8로 높아졌으며, 발효 7일 동안 유사한 pH값을 나타내었다. 산도는 발효 3일에 가장 높은 1.3%를 나타낸 후 발효 5일에 급격하게 감소하는 경향을 보였다. The pH of the lactic acid fermented extract from the green crab tended to increase during the fermentation period with increasing concentration of MSG. In the case of MSG 2.5% addition, it decreased to pH 4.3 on the 1st day of fermentation and increased to pH 4.8 with slight increase on 3 days of fermentation and showed similar pH value during 7 days of fermentation. The acidity showed the highest 1.3% after 3 days of fermentation and then decreased rapidly on the 5th day of fermentation.

MSG 농도가 3.5%, 4.5% 인 경우에 초기 pH 6.2에서 발효 1일에 4.5 정도도 감소한 후 발효 3일부터 증가하면서 발효 5일에는 각각 6.8, 7.1로 높아졌다. 산도는 발효 1일에 0.8%에서 발효기간이 증가하면서 급격하게 감소하면서 발효 3일에 0.15% 정도도 매우 낮은 값을 나타내었다(도 2). MSG concentration was increased from 3 days after fermentation to 4.5 and 6.8 and 5 days after fermentation, respectively. The acidity of the fermentation decreased rapidly with increasing fermentation period at 0.8% on the first day of fermentation, and was very low as about 0.15% on the third day of fermentation (FIG. 2).

따라서 녹각 추출물의 젖산발효 과정에서 산생성에도 불구하고 산도가 낮아지는 현상은 GABA생성 과정에서 수소이온을 소진되면서 나타나는 현상으로 사료되었다. Therefore, the pH of lactic acid extract was lowered in lactic acid fermentation process despite the acid production. This phenomenon appears to be caused by depletion of hydrogen ion during GABA production.

생균수 측정 결과, 목이버섯이 첨가되지 않은 경우에 발효 1일에 8×108에서 발효 3일에 1.5×109으로 가장 높은 값을 보인 후 완만하게 감소하였다. 반면에 목이버섯이 첨가된 경우에 발효 1일 생균수는 4.5×109으로 높은 값을 보였으며, 발효 3일에 1.9×109으로 가장 높은 값을 보인 후 완만하게 감소하였다. 따라서 목이버섯 첨가가 젖산 발효중에 생균수를 증진시키는 효과가 있는 것으로 나타났다(표 1).The viable cell counts showed the highest value at 8 × 10 8 on the first day of fermentation and 1.5 × 10 9 on the third day of fermentation without the addition of the mushroom. On the other hand, the number of viable cells per day of fermented mushroom was 4.5 × 10 9, and the highest value was 1.9 × 10 9 on the third day of fermentation. Therefore, it was shown that the addition of thymus mushroom had an effect on the number of viable cells during lactic acid fermentation (Table 1).

또한, 목이버섯 첨가조건에서 MSG의 농도가 2.5%~4.5%로 첨가되는 경우에 발효 1일에 최고 높은 생균수 값을 보였으며, 발효기간이 증가되면서 완만하게 생균수가 감소하는 경향을 보였다. 특히, MSG 농도가 높은 경우에 발효 7일에 생균수가 가장 높은 것으로 나타났다(도 3). When MSG concentration was added 2.5% ~ 4.5% at the addition of thymus mushroom, the highest viable cell count was observed on the 1st day of fermentation, and the number of viable cells tended to decrease gradually with increasing fermentation period. In particular, when the concentration of MSG was high, the number of live bacteria was highest at 7 days of fermentation (FIG. 3).

Figure pat00001
Figure pat00001

(2) GABA 생산(MSG 2.5~4.5%)(2) GABA production (MSG 2.5-4.5%)

GABA 함량 변화를 비교하기 위해 TLC를 이용하여 정성분석 한 결과는 도 4 및 도 5와 같다. 발효 1일부터 발효 7일까지 GABA가 점차적으로 생성되기 시작하였고, 발효 7일에 MSG가 대부분 전환되었다. 목이버섯이 존재하는 경우에 발효 5일에 대부분 MSG가 전환되면서 젖산균에 의한 GABA 생산이 보다 효과적이었다(도 4). The results of qualitative analysis using TLC to compare changes in GABA content are shown in FIGS. 4 and 5. GABA was gradually produced from fermentation 1 to fermentation 7 days, and MSG was mostly converted at 7 days of fermentation. GABA production by lactic acid bacteria was more effective when MSG was converted on the 5th day of fermentation when thrips were present (Fig. 4).

첨가되는 기질로서 MSG 함량이 2.5%에서 4.5%로 증가할 때 녹각 추출물에 목이버섯이 첨가된 경우에 젖산발효 3일에 대부분의 MSG가 이용되면서 GABA로 전환되었다. 따라서 녹각 추출물에 목이버섯 첨가에 따라 고농도 GABA생산이 가능하였다(도 5).When the MSG content was increased from 2.5% to 4.5% as a substrate to be added, most MSG was converted to GABA on the third day of fermentation of lactic acid when the thymus was added to the extract of the wax extract. Therefore, it was possible to produce high concentration GABA according to the addition of throat mushroom to the extract of the green peach (Fig. 5).

<< 실시예Example 2> 목이버섯 및 녹각추출물 복합 젖산발효액의 항산화 효능평가 2> Antioxidant efficacy of mixed lactic acid fermented extract

1. 목이버섯 및 녹각추출물 복합 젖산발효액 제조1. Manufacture of fermented lactic acid complex of throat mushroom and green tea extract

상기 실시예 1에서 제조된 녹각 추출물 200mL에 목이버섯 분말을 5 내지 20g 넣은 후, 효모 추출물(yeast extract) 1g, 포도당(glucose) 2g, MSG 5 내지 10g을 첨가하여 121℃에서 15분간 열처리하였다. 그리고 각각의 시료에 락토바실러스 플란타륨(L. plantarum) EJ2014 스타터(starter)를 1% 접종하고 30℃ 인큐베이터에서 3일간 배양한 후 발효물을 제조하였다. 5 g to 20 g of thistle mushroom powder was added to 200 mL of the green tea extract prepared in Example 1, 1 g of yeast extract, 2 g of glucose and 5 to 10 g of MSG were added and heat-treated at 121 ° C for 15 minutes. Each sample was inoculated with 1% of Lactobacillus plantarum EJ2014 starter and cultured in a 30 ° C incubator for 3 days to prepare a fermented product.

2. 총 폴리페놀 함량 측정2. Total polyphenol content measurement

팽이버섯 분말 발효 전과 발효 후 시료를 5배로 희석한 다음 60 μL을 취하여 Folin 시약(원액을 2배 희석한 액) 60 μL를 가하여 3분간 방치한 후 10% Na2CO3 용액 60 μL를 가하여 반응시켜 반응액의 흡광도를 700 nm에서 측정하였다. 표준곡선을 증류수로 0.1% (w/v)를 제조한 후 최종농도가 0, 20, 40, 60, 80, 100 μg/mL 용액이 되도록 조제하고 이를 일정량 취하여 위와 같은 방법으로 700 nm에서 흡광도를 측정하여 계산하였다.After the fermentation of the mushroom powder and the fermentation, dilute the sample 5 times, then add 60 μL of the Folin reagent (2 times dilution of the original solution) for 3 minutes, add 60 μL of 10% Na 2 CO 3 solution And the absorbance of the reaction solution was measured at 700 nm. Prepare a standard curve with 0.1% (w / v) of distilled water and make final concentrations of 0, 20, 40, 60, 80 and 100 μg / mL. Respectively.

3. 총 플라보노이드 함량 측정3. Total flavonoid content measurement

팽이버섯 분말 발효 전과 발효 후 시료 0.5 mL에 10% 알루미늄 니트레이트(aluminium nitrate)와 1 M 포타슘 아세테이트(potassium acetate)를 각각 0.1 mL, 80% 에탄올(ethanol) 4.3 mL을 가하여 실온에 40분 방치한 뒤 415 nm에서 흡광도를 측정하였다. 표준곡선을 증류수로 quercetin 0.1% (w/v)를 제조한 후 최종 농도가 0, 50, 100, 150, 200 μg/mL 용액이 되도록 조제하고 이를 일정량 취하여 위와 같은 방법으로 415 nm에서 흡광도를 측정하여 계산하였다. 0.1 mL of 10% aluminum nitrate and 1 M potassium acetate and 4.3 mL of 80% ethanol were added to 0.5 mL of the sample before and after the fermentation of the powdery mushroom powder and allowed to stand at room temperature for 40 minutes The absorbance was measured at 415 nm. Prepare quercetin 0.1% (w / v) as a standard curve with distilled water and make final concentrations of 0, 50, 100, 150, and 200 μg / mL. Measure the absorbance at 415 nm Respectively.

4. 4. DPPHDPPH radical 소거 활성 측정 Measurement of radical scavenging activity

목이버섯 첨가 전후 녹각 추출물 젖산발효물 시료 160 μL와 에탄올에 녹인 0.15 mM DPPH 용액 40 μL를 가하여 실온에서 30분 방치한 후 517nm에서 흡광도를 측정하였다. 각 시료 추출물의 유리 라디칼 소거활성은 시료를 첨가하지 않은 대조구의 흡광도를 1/2로 환원시키는데 필요한 시료의 농도인 IC50 값으로 나타내었다. 이 때 상대 활성의 비교를 위하여 대조군으로 butylated hydroxy anisole (BHA)를 사용하였다.Before and after the addition of thymus mushroom, 160 μL of the extract of lactic acid and 30 μL of a 0.15 mM DPPH solution dissolved in ethanol was added to the sample. The absorbance was measured at 517 nm after 30 minutes at room temperature. The free radical scavenging activity of each sample extract was expressed as IC 50 , the concentration of the sample required to reduce the absorbance of the control without addition of the sample to ½. For comparison of relative activities, butylated hydroxy anisole (BHA) was used as a control.

5. 5. ABTSABTS radical 소거 활성 측정 Measurement of radical scavenging activity

7 mM 2,2-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)와 2.45 mM 포타슘 퍼설페이트(potassium persulfate)를 최종 농도로 혼합하여 실온인 암소에서 24시간 동안 방치하여 ABTS+를 형성시킨 후 732nm에서 흡광도 값이 0.70 (±0.02)이 되게 포스페이트 완충액 식염수(phosphate buffer saline; PBS, pH 7.4)로 희석하였다. 희석된 용액 180μL에 샘플(sample) 20 μL를 가하여 정확히 1분 동안 방치한 후 흡광도를 측정하였다.7 mM 2-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) and 2.45 mM potassium persulfate were mixed at a final concentration and allowed to stand in a dark room at room temperature for 24 hours to form ABTS + Was diluted with phosphate buffer saline (PBS, pH 7.4) so that the absorbance value was 0.70 (+/- 0.02). 20 μL of sample was added to 180 μL of the diluted solution, and the solution was allowed to stand for exactly one minute, and the absorbance was measured.

6. 결과 및 고찰6. Results and discussion

(1) 폴리페놀 함량과 플라보노이드 함량 측정(1) Determination of polyphenol content and flavonoid content

녹각 추출물에 목이버섯을 첨가 및 발효 전후에 총 폴리페놀 함량과 플라보노이드 함량을 측정해 본 결과, 목이버섯이 첨가되지 않은 경우 발효 전 폴리페놀 함량은 22.67 mg/mL, 플라보노이드 함량은 10.90 mg/mL으로 나타났으며 발효 후 폴리페놀 함량은 20.53 mg/mL, 플라보노이드 함량은 17.36 mg/mL로 나타나면서 비교적 녹각추출물의 페놀화합물의 함량이 높은 것으로 사료되었다. 또한 목이 버섯이 첨가된 경우에 발효전 발효 전 폴리페놀 함량은 19.11 mg/mL, 플라보노이드 함량은 18.25 mg/mL으로 나타났으며 발효 후 폴리페놀 함량은 21.42 mg/mL, 플라보노이드 함량은 13.69 mg/mL로 나타났다(표 2). The total polyphenol contents and flavonoid contents were measured before and after fermentation. The content of polyphenol before fermentation was 22.67 mg / mL and flavonoid content was 10.90 mg / mL before fermentation. The contents of polyphenols and flavonoids were higher than those of other extracts. In addition, the content of polyphenol and flavonoid were 19.11 mg / mL and 18.25 mg / mL, respectively, before fermentation, and 21.42 mg / mL and 13.69 mg / mL, respectively, (Table 2).

Figure pat00002
Figure pat00002

(2) DPPH radical 소거능 (2) DPPH radical scavenging ability

DPPH radical 소거 활성법을 이용한 녹각 추출물의 목이버섯 첨가 유무에 따른 젖산 발효물의 항산화력을 측정한 결과는 표 3과 같다. 목이버섯 첨가 없이 발효전 녹각 추출물의 희석배수 10, 50, 70에서 각각 76.01%, 50.00%, 41.11%의 저해능을 보이는 것으로 나타났으며, 50% 항산화능을 나타내는 농도 값을 나타내는 IC50 값은 0.17 mg/mL이었다. 목이버섯 첨가전 젖산 발효물의 radical 소거능은 희석배수 10, 50, 70에서 각각 87.22%, 53.88%, 50.55%로 나타났으며 IC50 값은 0.11 mg/mL로 발효전보다 낮은 값을 나타내었다. DPPH radical 소거능은 녹각 추출물을 젖산발효시킨 발효물이 더 적은 농도에서 50%의 활성을 보이는 것으로 보아 발효 후가 더 항산화 활성이 더 우수한 것으로 판단되었다. 또한 목이버섯이 첨가된 녹각 추출물의 희석배수 10, 50, 70에서 각각 라디칼 소거능이 57.86%, 58.18%, 52.22%로 나타났으며, 목이버섯 첨가된 후 젖산발효물은 각각 73.33%, 49.44%, 42.77%로 나타났다. 목이버섯 첨가의 경우에 발효 전후에 50% 활성을 보이는 IC50 값이 각각 0.12 mg/mL, 0.11 mg/mL로서 유사한 값을 나타내었다. DPPH 라디칼 소거능으로 평가된 항산화 활성은 녹각 추출물에 목이버섯 첨가 및 젖산발효에 의해서 IC50 값이 적은 것으로 나타나면서 항산화활성이 높은 것으로 확인되었다(표 3).The antioxidant activity of lactic acid fermented product was evaluated by DPPH radical scavenging activity according to the presence or absence of thymus mushroom in the antler extract. 50, and 41.11% at 10, 50, and 70 dilution ratios of pre - fermented green peach extract without addition of thymus mushroom, respectively. IC 50 values indicating 50% antioxidant capacity were 0.17 mg / mL. The radical scavenging activity of lactic acid fermented before addition of thymus mushroom was 87.22%, 53.88%, and 50.55% at dilution ratios of 10, 50 and 70, respectively. IC 50 value was 0.11 mg / mL lower than that before fermentation. The DPPH radical scavenging activity was 50% at the lower concentration of the fermented lactic acid fermented with the extract of the green algae. The radical scavenging activities were 57.86%, 58.18% and 52.22% at dilution ratios of 10, 50 and 70, respectively. The fermented lactic acid was 73.33% and 49.44% after the addition of thymus mushroom, respectively. 42.77%. IC 50 values of 50% activity before and after fermentation were 0.12 mg / mL and 0.11 mg / mL, respectively. The antioxidant activity is evaluated by the DPPH radical scavenging activity while shown to the neck low IC 50 values by the addition of mushroom and lactic acid fermentation to overgrown antler extract was found to have high antioxidant activity (Table 3).

Figure pat00003
Figure pat00003

(3) ABTS radical 소거능 측정(3) Measurement of ABTS radical scavenging ability

ABTS 포타슘 퍼설페이트(potassium persulfate)를 암소에 방치하여 ABTS+가 생성되면 시료의 항산화력에 의해 ABTS+가 소거되어 radical 특유의 청록색이 탈색 되는데 이를 흡광도 값으로 나타내어 ABTS+의 소거 활성능을 측정하였다. 목이버섯 첨가전 녹각 추출물의 희석배수 10, 50, 100에서 각각 74.56%, 27.93%, 17.76%의 저해능을 나타내었으며 IC50 값은 2.83 mg/mL이었다. 목이버섯 첨가전 녹각 추출물 젖산발효액의 ABTS radical 소거능은 유사한 radical 소거능을 보이면서 IC50 값은 2.83 mg/mL을 나타내었다. After ABTS + potassium persulfate was incubated in the dark, ABTS + was removed by the antioxidant activity of the sample. The ABTS + was discolored due to the discoloration of the specific cyan color. In the dilution ratios of 10, 50 and 100, the extracts showed 74.56%, 27.93% and 17.76%, respectively, and the IC 50 value was 2.83 mg / mL. The ABTS radical scavenging activity of lactic acid fermentation extracts showed similar radical scavenging activity and IC 50 value was 2.83 mg / mL.

목이버섯이 첨가된 녹각추출물의 ABTS radical 소거능은 희석배수 10, 50, 100에서 각각 71.63%, 29.88%, 18.84%로 나타났으며 IC50 값은 2.62 mg/mL을 나타내었다. 목이버섯 첨가된 녹각 추출물 젖산발효물의 ABTS radical 소거능은 희석배수 10, 50, 100에서 각각 80.49%, 27.88%, 15.99%로 IC50 값은 2.71 mg/mL로 발효 전후에 유사한 항산화 활성을 나타내었다. 목이버섯의 첨가에 따라서 발효 유무에 관계없이 ABTS radical 소거능이 우수한 것으로 나타났다(표 4). The ABTS radical scavenging activity of the extracts of P. vannamei was 71.63%, 29.88% and 18.84% in dilution ratios of 10, 50 and 100, respectively, and the IC 50 value was 2.62 mg / mL. The ABTS radical scavenging activity of lactic acid fermented with the thymus mushroom was 80.49%, 27.88%, and 15.99% at dilution ratios of 10, 50 and 100, respectively. The IC 50 value was 2.71 mg / mL and showed similar antioxidative activities before and after fermentation. As shown in Table 4, ABTS radical scavenging ability was excellent regardless of fermentation depending on the addition of thistle mushroom.

Figure pat00004
Figure pat00004

<< 실시예Example 3> 목이버섯 및 녹각추출물 복합 젖산발효액의 염증완화 효능 평가 3> Assessment of inflammation mitigation efficacy of fermented lactic acid mixture

1. 세포 생존율1. Cell viability

RAW cell의 생존율은 목이버섯이 첨가되지 않은 녹각추출액의 경우에 발효전의 시료는 15배 희석까지 세포 독성은 없었으며, 5배 희석인 경우에서 약간의 세포 독성을 보였다 반면에 발효시킨 시료의 경우에 5배 희석된 시료에서도 세포 독성이 완화되면서 control수준으로 세포 생존율이 올라가는 것으로 나타났다(도 6).The survival rate of RAW cells was not cytotoxic until 15-fold dilution, but slightly cytotoxic in 5-fold dilution, when fermented samples were not fermented. The cytotoxicity was also alleviated in the 5-fold diluted samples and the cell survival rate was increased to the control level (Fig. 6).

목이버섯이 첨가된 녹각 추출물의 경우에 젖산발효전 시료는 15배 희석된 시료에서 세포 독성은 보이지 않았지만, 5배 희석된 시료에서 세포 독성을 보였다. 반면에 발효시킨 시료의 경우에 5배 희석된 시료에서 세포 독성이 완화되면서 세포 생존율이 높아지는 것으로 나타났다. 따라서 목이버섯의 첨가된 녹각추출물은 발효에 의해서 RAW cell의 세포독성이 완화되는 것으로 판단되었다(도 7). In the case of green peach extract added with thymus mushroom, the lactic acid fermented sample showed no cytotoxicity in the 15-fold diluted sample but cytotoxic in the 5-fold diluted sample. On the other hand, in the case of the fermented samples, the cell viability was improved by decreasing the cytotoxicity in the 5-fold diluted sample. Therefore, it was judged that the agaricus extract added with Thymus mushroom alleviated cytotoxicity of RAW cells by fermentation (FIG. 7).

2. NO 생성2. NO generation

RAW cell의 LPS 물질 유도에 따라서 생성된 NO의 생성 정도를 비교하였다. 목이버섯이 첨가되지 않은 녹각 추출액의 경우에 발효 전의 시료는 15배 희석에서 NO 생성 억제 효과를 보였으며, 이보다 높은 농도인 5배 희석인 경우에 세포독성에 기인한 NO 생성의 억제로 사료되었다. 반면에 발효시킨 시료의 경우에 15배 희석된 시료에서도 NO 생성의 억제가 미비하였다(도 8). The production of NO produced by the induction of LPS material in RAW cells was compared. In the case of the waxy extract without addition of thymus mushroom, the pre-fermentation sample showed an inhibitory effect on NO production in the 15-fold dilution. In the case of the 5-fold dilution, the inhibition of NO production due to cytotoxicity was considered. On the other hand, in the case of fermented samples, inhibition of NO production was not observed even in a sample diluted 15 times (Fig. 8).

목이버섯이 첨가된 녹각 추출물의 경우에 젖산 발효 전 시료는 15배 희석된 시료에서 NO 생성 억제가 미비하였으며, 5배 희석된 시료의 경우에 NO 생성이 크게 억제되었다. 이는 세포 독성에 기인한 현상으로 사료되었다. 반면에 발효시킨 시료의 경우에 5배 희석된 시료에서 NO 생성이 억제되었다. 발효된 시료는 세포 독성이 완화된 경우를 고려할 때 목이버섯 첨가 및 젖산발효에 의해서 NO 생성이 억제되는 것으로 판단되었다(도 9).In the case of the green peach extract added with thymus mushroom, NO production inhibition was insignificant in samples diluted 15 times before lactic acid fermentation, and NO production was significantly inhibited in samples diluted 5 times. This was thought to be due to cytotoxicity. On the other hand, in fermented samples, NO production was inhibited in 5 times diluted samples. Considering the case where the cytotoxicity of the fermented sample was alleviated, it was judged that NO production was inhibited by the addition of thymus mushroom and lactic acid fermentation (FIG. 9).

한국미생물보존센터(국외)Korea Microorganism Conservation Center (overseas) KCCM11545PKCCM11545P 2014060920140609

Claims (7)

(1) 녹각을 열수 추출하여 녹각 추출액을 제조하는 단계;
(2) 상기 제조된 녹각 추출액에 목이버섯, 모노소듐 글루타메이트(monosodium glutamate; MSG), 포도당(glucose) 및 효모 추출물(yeast extract)를 첨가하여 혼합하는 단계;
(3) 상기 혼합물을 열처리하는 단계; 및
(4) 상기 열처리된 혼합물에 젖산균(Lactobacillus) 스타터를 접종하고 배양하여 젖산 발효시키는 단계를 포함하는 항산화 활성 및 감마-아미노뷰티르산(gammaaminobutyric acid; GABA) 증진된 녹각추출물 및 목이버섯 복합 젖산발효액 제조방법.
(1) preparing a green leaf extract by hot water extraction of a green leaf;
(2) adding and mixing monosodium glutamate (MSG), glucose, and yeast extract to the above-prepared extract of green tea leaves;
(3) heat treating the mixture; And
(4) an antioxidative activity including lactic acid fermentation by inoculating a lactobacillus starter into the heat-treated mixture and culturing the lactic acid bacteria and gamma-aminobutyric acid (GABA) enhanced guano extract and a fermented broth Way.
제1항에 있어서, 상기 (2) 단계는 전체 녹각 추출액 100 중량부에 대해, 목이버섯 0.1 내지 10 중량부, MSG 1 내지 5 중량부, 포도당(glucose) 1 내지 5 중량부 및 효모 추출물(yeast extract) 0.1 내지 3 중량부를 첨가하여 혼합하는 것을 특징으로 하는 항산화 활성 및 GABA 증진된 녹각추출물 및 목이버섯 복합 젖산발효액 제조방법. [3] The method according to claim 1, wherein the step (2) comprises adding 0.1 to 10 parts by weight of mushroom, 1 to 5 parts by weight of MSG, 1 to 5 parts by weight of glucose, and yeast extract extract and 0.1 to 3 parts by weight of the extract are mixed and then mixed. 제1항에 있어서, 상기 젖산균(Lactobacillus)은 락토바실러스 플란타륨(Lactobacillus plantarum) EJ2014 (KCCM11545P) 균주인 것을 특징으로 하는 항산화 활성 및 GABA 증진된 녹각추출물 및 목이버섯 복합 젖산발효액 제조방법.The method according to claim 1, wherein the Lactobacillus is Lactobacillus plantarum EJ2014 (KCCM11545P). The method of claim 1, wherein the lactic acid bacterium is Lactobacillus plantarum EJ2014 (KCCM11545P). 제1항에 있어서, 상기 (4) 단계의 발효는 25 내지 30℃에서, 1 내지 10일 동안 발효하는 것을 특징으로 하는 항산화 활성 및 GABA 증진된 녹각추출물 및 목이버섯 복합 젖산발효액 제조방법.The method according to claim 1, wherein the fermentation in step (4) is fermented at 25 to 30 ° C for 1 to 10 days, and the method for producing the fermented liquid of LABORATORY EXAMPLES. 제1항 내지 제5항 중 어느 하나의 항의 방법에 의해 제조된 항산화 활성 및 GABA 증진된 녹각추출물 및 목이버섯 복합 젖산발효액.An antioxidative activity and a GABA-enhanced antioxidant extract prepared by the method of any one of claims 1 to 5 and a fermented liquid of mixed lactic acid of chestnut mushroom. 락토바실러스 플란타륨(Lactobacillus plantarum) EJ2014 (KCCM11545P) 균주로 발효시킨 녹각추출물 및 목이버섯 복합 젖산발효액을 유효성분으로 포함하는 염증 개선용 식품조성물.A composition for improving inflammation, comprising as an active ingredient, a green tea extract fermented with a strain of Lactobacillus plantarum EJ2014 (KCCM11545P) and a lactic acid fermentation solution of a mixture of Lactobacillus plantarum and Lactobacillus japonica. 제6항에 있어서, 상기 녹각추출물 및 목이버섯 복합 젖산발효액은 항산화 활성 및 GABA가 증진된 것을 특징으로 하는 염증 개선용 식품조성물.[Claim 7] The composition for improving inflammation according to claim 6, wherein the antioxidative activity and the GABA are enhanced in the fermentation broth of the Lactobacillus japonica extract and the mushroom complex lactic acid.
KR1020160075025A 2016-06-16 2016-06-16 Method for manufacturing old antler and Auricularia judae fermented solution by lactic acid fermentation and food composition for improving inflammation comprising the fermented solution KR101826148B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160075025A KR101826148B1 (en) 2016-06-16 2016-06-16 Method for manufacturing old antler and Auricularia judae fermented solution by lactic acid fermentation and food composition for improving inflammation comprising the fermented solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160075025A KR101826148B1 (en) 2016-06-16 2016-06-16 Method for manufacturing old antler and Auricularia judae fermented solution by lactic acid fermentation and food composition for improving inflammation comprising the fermented solution

Publications (2)

Publication Number Publication Date
KR20170141952A true KR20170141952A (en) 2017-12-27
KR101826148B1 KR101826148B1 (en) 2018-02-06

Family

ID=60938625

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160075025A KR101826148B1 (en) 2016-06-16 2016-06-16 Method for manufacturing old antler and Auricularia judae fermented solution by lactic acid fermentation and food composition for improving inflammation comprising the fermented solution

Country Status (1)

Country Link
KR (1) KR101826148B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101852313B1 (en) * 2017-12-29 2018-04-25 오호진 mushroom extract containing mushroom active ingredient manufacturing method and Kimchi containing mushroom extract
CN109601781A (en) * 2018-11-29 2019-04-12 江苏康泰源食品有限公司 A kind of preparation method of agaric ferment
CN110923171A (en) * 2019-12-20 2020-03-27 黑河君行生物科技有限责任公司 Lactic acid bacteria for removing earthy taste of black fungus and enzyme preparation method thereof
KR20210000539A (en) * 2019-06-25 2021-01-05 계명대학교 산학협력단 Functional fermented material of auricularia auricula-judae by mixed fermentation and manufacturing method thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102073480B1 (en) 2018-06-26 2020-02-04 계명대학교 산학협력단 Method for manufacturing functional fermented material of apple juice and Auricularia judae by mixed fermentation with yeast and lactic acid bacteria
KR20220130967A (en) 2021-03-19 2022-09-27 서원대학교산학협력단 Fermented extract of Young Antler with Enhanced Anti-oxidant Activity

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101852313B1 (en) * 2017-12-29 2018-04-25 오호진 mushroom extract containing mushroom active ingredient manufacturing method and Kimchi containing mushroom extract
CN109601781A (en) * 2018-11-29 2019-04-12 江苏康泰源食品有限公司 A kind of preparation method of agaric ferment
KR20210000539A (en) * 2019-06-25 2021-01-05 계명대학교 산학협력단 Functional fermented material of auricularia auricula-judae by mixed fermentation and manufacturing method thereof
CN110923171A (en) * 2019-12-20 2020-03-27 黑河君行生物科技有限责任公司 Lactic acid bacteria for removing earthy taste of black fungus and enzyme preparation method thereof
CN110923171B (en) * 2019-12-20 2021-07-27 黑河君行生物科技有限责任公司 Lactic acid bacteria for removing earthy taste of black fungus and enzyme preparation method thereof

Also Published As

Publication number Publication date
KR101826148B1 (en) 2018-02-06

Similar Documents

Publication Publication Date Title
KR101826148B1 (en) Method for manufacturing old antler and Auricularia judae fermented solution by lactic acid fermentation and food composition for improving inflammation comprising the fermented solution
Sahu et al. Preparation and evaluation of wine from tendu (Diospyros melanoxylon L) fruits with antioxidants
KR101402031B1 (en) Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154
KR101814867B1 (en) Processed food composition Mulberry Fruit using Traditional Jar and its manufacturing method thereof
KR20220025679A (en) Method for producing fermented apple postbiotics with increased effective component content using lactic acid bacteria
KR101616187B1 (en) Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus
JP6955808B1 (en) How to make fermented honey
CN105567533A (en) Probiotic anti-oxidation health vinegar production method
KR20220025680A (en) Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria
KR101944183B1 (en) Method for manufacturing yeast starter containing apple pomace and Auricularia judae by mixed fermentation with lactic acid bacteria and yeast
CN113951409B (en) Viable bacteria type fermented juice of aronia melanocarpa and processing method thereof
KR101733549B1 (en) Wine or vinegar of Orostachys japonicus made from fermented sugar extract of Orostachys japonicus
KR101969708B1 (en) Powder makgeolli composition containing DIY kit type lactic acid bacterium, method of preparing the composition, and makgeolli
KR20200145127A (en) Composition and method for yogurt with enhanced GABA using barley and yogurt produced by the same
KR101530661B1 (en) Method for Preparing Makgeolli Using Monascus sp. and Makgeolli Prepared Thereby
KR101380920B1 (en) Fermented jam comprising fermented opuntia humifusa fruit by lactic acid bacteria
KR101582728B1 (en) Method for manufacturing Cornus Officinalis jam using GABA producing Lactobacillus and lactic acid apple pomace
KR20220025681A (en) Method for producing fermented cranberry postbiotics with increased effective component content using lactic acid bacteria
KR101629074B1 (en) Method for manufacturing lactic acid fermented pudding using sweet pumpkin powder containing lactic acid fermented tumeric
CN109170721B (en) Fermented low-sugar Chuzhou chrysanthemum petal suspension sauce and preparation method thereof
KR20220101230A (en) Kombucha vinegar containing Rubus coreanus and manufacturing method thereof
KR101863760B1 (en) Fermented vinegar with aloe, and manufacturing method thereof
Moirangthem et al. Enzyme technology for value addition in the beverage industry waste
KR20190084917A (en) Manufacturing method of vinegar using black rice and sugar fermented liquor and vinegar manufactured thereby
KR20160116664A (en) The manufacturing method of fermentation vinegar using sevenberry concentration solution and beverage base composition containing sevenberry fermentation vinegar

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right